Skip to content

Does Sevoflurane Cause Genomic Damage

Does Sevoflurane Induce Genomic Instability in Patients Undergoing General Anaesthesia?

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03109119
Enrollment
30
Registered
2017-04-12
Start date
2018-09-01
Completion date
2019-12-31
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia; Adverse Effect

Keywords

genomic instability, Sevoflurane, General anaesthesia

Brief summary

This study aims to find out if sevoflurane causes any cell damage to patients undergoing general anaesthesia. In case of any damage, the reversibility of the damage is also assessed. This is a prospective, comparative study carried out in all children scheduled for surgical repair of cleft lip or palate admitted in the Department of Plastic Surgery under Smile Train organisation ìn our hospital,who satisfy the inclusion and exclusion criteria.

Detailed description

STUDY GOALS AND OBJECTIVES 1. To find out if sevoflurane induces genomic instability in children undergoing cleft lip and palate repair. 2. To assess the magnitude of genomic damage caused by the sevoflurane anaesthesia. 3. To evaluate the reversibility of the induced genomic instability when exposure is discontinued. STUDY DESIGN Type of study : Prospective Comparative Study Research population : All children scheduled for surgical repair of cleft lip or palate admitted in the Department of Plastic Surgery of our hospital, who satisfy the inclusion and exclusion criteria. Sample Size : A total of 30 children will be enrolled for the study. METHODOLOGY Children scheduled to undergo surgical repair of cleft lip or palate were enrolled for the study, after addressing the inclusion and exclusion criteria. A peripheral blood sample of 1.5 ml (S-1) will be taken before the induction of anaesthesia .All children will be randomly allocated into two groups - group S and P.All children will be premedicated with Inj.Glycopyrolate 0.01 mg/kg . Children in group S will be induced with sevoflurane, whereas children in group P will be induced with propofol.All children will be intubated using I / V Vecuronium 0.1 mg / kg .Analgesia will be provided using I / V Fentanyl 1.5 mcg / kg. Depth of anaesthesia will be maintained with sevoflurane in group S and with propofol infusion in group P. The vitals will be monitored as usual intraop and the children will be extubated at the end of the surgery. Peripheral blood samples of 1.5 ml each will be taken immediately after extubation (S-2) , after 48 hours (S-3)and after 120 hours (S-4).A fifth blood sample (S-5) will be taken on the 14th postoperative day All the blood samples will be evaluated for genomic instability using Alkaline Comet Assay by the Genetics Lab of our hospital. STATISTICAL ANALYSIS The findings of this study will be analysed using Chi-square test, Student's t-test, Mann-Whitney U test, mean and standard deviation to yield the final results. The study will be considered statistically significant with a p value of less than 0.05

Interventions

DRUGSevoflurane

The patients in the group S will be exposed to routine concentrations of sevoflurane during anaesthesia.

DRUGPropofol

These patients will be induced with propofol 1.5 mg / kg and maintained with propofol infusion.

Sponsors

Jubilee Mission Medical College and Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

This is a double blinded study, where the participants are randomly selected using a computer - generated number and allocated to any one of the two groups. Both the patient and the outcome assessor will be blinded.

Intervention model description

All children will be randomly allocated into two groups - group S and P. Children in group S will be anaesthetised with sevoflurane, whereas children in group P will be anaesthetised with propofol. Peripheral blood samples of 1.5 ml each will be taken immediately after extubation (S-2) , after 48 hours (S-3)and after 120 hours (S-4).A fifth blood sample (S-5) will be taken on the 14th postoperative day. These blood samples will be evaluated for genomic instability using Alkaline Comet Assay and micronucleus test by the Genetics Lab of our hospital.

Eligibility

Sex/Gender
ALL
Age
6 Months to 12 Months
Healthy volunteers
No

Inclusion criteria

* Children must have isolated cleft lip or palate. * The surgery must be a primary repair of cleft lip or palate. * The minimum duration of the surgery must be 90 minutes.

Exclusion criteria

* Children who have undergone previous surgery. * Children who have syndromic cleft lip or palate. * Children with bleeding disorders. * Children with known allergy to any of the concerned drugs.

Design outcomes

Primary

MeasureTime frameDescription
Genomic instabilityIt will be assessed at 2 hours after anaesthesia.Genomic instability will be assessed using comet assay

Secondary

MeasureTime frameDescription
Reversibility of the genomic instabilityIt will be assessed on fifth day after anaesthesia.Assessed using comet assay
Reversibility of genomic instabilityIt will be assessed on the 14th day after anaesthesia.It will be assessed using comet assay.

Countries

India

Contacts

Primary ContactVigil Peter, MD
drpeteralapatt@gmail.com918593821000
Backup ContactAlex George, PhD
alexgeorge@jmmc.ac.in914872432200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026